Inclusion completed

Safety and pharmacokinetics of ODM-201 in patients with castrate resistant prostate cancer: open, non-randomised, uncontrolled, multicentre, multiple dose escalation study with randomised phase II expansion component

Cancer type: Prostate cancer

Phase: I/II

Principal Investigator: Bono Petri

Country: FI

Keywords: Finland, Prostate cancer

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01317641